Kovai Medical Center and Hospital Promoter Buying: ₹0.31 Cr
Promoter entity Pavai Property Developers Private Limited purchased 500 equity shares of Kovai Medical Center & Hospital Ltd via market acquisition.
- Value
- ₹0.31 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Promoter entity Pavai Property Developers Private Limited purchased 500 equity shares of Kovai Medical Center & Hospital Ltd via market acquisition.
Kovai Medical Center shareholders approved Dr. Arun N Palaniswami's re-designation as Joint Managing Director via postal ballot. The resolution passed with 96% assent in September 2026.
Kovai Medical Center and Hospital Limited has issued a Postal Ballot Notice seeking shareholder approval for the re-designation of Dr. Arun N Palaniswami as Joint Managing Director.
Promoter Palaniswami N acquired 12,59,725 shares (11.51% stake) of Kovai Medical Center via inheritance. His total holding increased from 0.09% to 11.60% post-transaction.
Kovai Medical Center and Hospital Limited has reconstituted its Corporate Social Responsibility Committee, effective from August 7, 2026. This is a routine governance update.
Kovai Medical Center and Hospital Ltd has re-designated Dr. Arun N Palaniswami as the Joint Managing Director of the company, effective August 07, 2026.
Kovai Medical Center and Hospital Ltd reported revenue from operations of ₹430.9 Cr (+15.3% YoY) and net profit of ₹69.1 Cr (+20.8% YoY) for Q1 FY27.
Kovai Medical Center & Hospital Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026, noting the transmission of shares due to a promoter's demise.
Kovai Medical Center and Hospital Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ended 31st March, 2026.
Kovai Medical Center and Hospital Limited has issued a notice for its Annual General Meeting on August 26, 2026. The agenda includes financial statements and dividend declaration.